Fawole Adeshina S, Simpson David J, Rajagopal Ramesh, Elder Jackie, Holland Tracey A, Fryer Anthony, Deakin Mark, Elder James B, Farrell William E
Centre for Cell and Molecular Medicine, School of Postgraduate Medicine, Keele University, North Staffordshire Hospital, Stoke-on-Trent, United Kingdom.
Int J Cancer. 2002 Jun 20;99(6):829-33. doi: 10.1002/ijc.10432.
Recent studies have shown that loss of heterozygosity (LOH) on chromosome 10q is a frequent event in a number of tumour types including colorectal cancers. Because previous studies have used markers located mainly distally on chromosome 10, we have examined 114 sporadic colorectal adenocarcinomas for LOH using a panel of 9 highly polymorphic microsatellite markers spanning the long arm of chromosome 10. Using microdissected tumour material, LOH of one or more chromosome 10q markers was a frequent event (75 of 114; 66%). The highest frequency of loss (42 of 96; 44%) was observed at the marker D10S1790 located at 10q21.1. The mean age of presentation, of patients with LOH of D10S1790 was significantly (p = 0.0006) lower (67.1 years) compared to patients with retention of this marker (73.5 years). When we compared frequency of loss at this marker in patients presenting before 70 years of age (68%) to those above 70 years (23%) we observed a significant difference (p < 0.0001). Statistical analysis between loss, or instability at other markers and clinicopathological features did not show any significant associations. In addition LOH at D10S1790 was infrequent in adenomas (2 of 20; 10%) compared to adenocarcinomas (42 of 96; 44%) (p = 0.0047), suggesting that loss within this region is a late event in colorectal tumorigenesis. The association of loss at D10S1790 and an earlier age of presentation in adenocarcinomas suggests that this locus may harbor a tumour suppressor gene(s), which affects the rate of colorectal tumour progression. Identification of this region of genetic loss further refines our understanding of the paradigm in this tumour type of multiple-steps responsible for initiation and progression.
最近的研究表明,10号染色体长臂杂合性缺失(LOH)在包括结直肠癌在内的多种肿瘤类型中是常见事件。由于先前的研究主要使用位于10号染色体远端的标记,我们使用一组跨越10号染色体长臂的9个高度多态性微卫星标记,对114例散发性结直肠腺癌进行了LOH检测。使用显微切割的肿瘤材料,一个或多个10号染色体长臂标记的LOH是常见事件(114例中的75例;66%)。在位于10q21.1的标记D10S1790处观察到最高的缺失频率(96例中的42例;44%)。与保留该标记的患者(73.5岁)相比,D10S1790发生LOH的患者的平均就诊年龄显著更低(67.1岁,p = 0.0006)。当我们比较70岁之前就诊的患者(68%)与70岁以上患者(23%)中该标记的缺失频率时,观察到显著差异(p < 0.0001)。其他标记的缺失或不稳定性与临床病理特征之间的统计分析未显示任何显著关联。此外,与腺癌(96例中的42例;44%)相比,腺瘤中D10S1790的LOH较少见(20例中的2例;10%)(p = 0.0047),这表明该区域内的缺失是结直肠癌发生过程中的晚期事件。D10S1790的缺失与腺癌较早的就诊年龄之间的关联表明,该位点可能含有一个肿瘤抑制基因,其影响结直肠癌的进展速度。对这一基因缺失区域的鉴定进一步完善了我们对这种肿瘤类型中负责起始和进展的多步骤模式的理解。